HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b. HIBERIX is approved for use in children aged 6 weeks through 4 years (prior to fifth birthday). (1) -----DOSAGE AND ADMINISTRATION----- For intramuscular administration only.
HIBERIX | FDA
Dec 21, 2023 · HIBERIX is indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b. HIBERIX is approved for use in children aged 6 weeks through 4 years...
About Hib Vaccine (Haemophilus Influenzae Type b Vaccine) - CDC
Hiberix ® (PRP-T) PedvaxHIB ® (PRP-OMB) Combination Vaccines. At some ages, a child needs to receive several different recommended vaccines simultaneously. Manufacturers created combination vaccines to decrease the number of injections needed to give these recommended vaccines at the same time.
Hiberix Vaccine: Uses, Age Limits, Schedule, Side Effects - Drugs.com
Nov 18, 2024 · Hiberix is used to prevent haemophilus B in children, and is sometimes combined with vaccines to protect against other diseases. Hiberix is given to children between the ages of 2 months and 18 months old.
Hib Vaccine Recommendations | H. influenzae | CDC
Jun 26, 2024 · 3 doses of ActHIB ®, Hiberix ®, Pentacel ®, or Vaxelis™ 2 doses of PedvaxHIB ® Vaccine providers can administer the first dose as early as age 6 weeks. Children 12 through 15 months of age. CDC recommends a booster dose of ActHIB ®, Hiberix ®, Pentacel ®, or PedvaxHIB ® at age 12 through 15 months. Administer the booster dose at least ...
Hiberix (Haemophilus B Conjugate Vaccine Tetanus Toxoid ... - RxList
HIBERIX® is indicated for active immunization as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b. HIBERIX is approved for use in children 15 months through 4 years of age (prior to fifth birthday).
Hiberix: Package Insert / Prescribing Information - Drugs.com
Feb 13, 2025 · Hiberix package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
ActHIB, Hiberix (haemophilus influenzae type b vaccine) dosing ...
Medscape - Indication-specific dosing for ActHIB, Hiberix (haemophilus influenzae type b vaccine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy &...
FDA approves expanded use of GSK Hib vaccine from booster dose to …
HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b. HIBERIX is approved for use in children 6 weeks through 4 years of age (prior to fifth birthday).
FDA Approves GlaxoSmithKline (GSK)'s Hib Vaccine, Hiberix(R)
Aug 20, 2009 · About Hiberix. Hiberix is indicated for active immunization as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b.